ReFacto

DRUG2 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

Hemophilia A

Phase 4

Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery

CompletedNCT00092976

Wyeth is now a wholly owned subsidiary of PfizerHemophilia A

Start: 2003-02-28End: 2007-07-31Target: 15Updated: 2007-12-28

Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A

WithdrawnNCT00168051

Wyeth is now a wholly owned subsidiary of PfizerHemophilia A

Start: 2005-04-30End: 2005-11-30Updated: 2018-09-25